[1]易晓明,彭小娜.氧气驱动雾化吸入对支气管哮喘患者肺功能及血氧饱和度的影响[J].医学信息,2019,32(23):110-111,114.[doi:10.3969/j.issn.1006-1959.2019.23.030]
　YI Xiao-ming,PENG Xiao-na.Effect of Oxygen-Driven Aerosol Inhalation on Lung Function and Oxygen Saturation in Patients with Bronchial Asthma[J].Medical Information,2019,32(23):110-111,114.[doi:10.3969/j.issn.1006-1959.2019.23.030]
点击复制

氧气驱动雾化吸入对支气管哮喘患者肺功能及血氧饱和度的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年23期
页码:
110-111,114
栏目:
临床研究
出版日期:
2019-12-01

文章信息/Info

Title:
Effect of Oxygen-Driven Aerosol Inhalation on Lung Function and Oxygen Saturation in Patients with Bronchial Asthma
文章编号:
1006-1959（2019）23-0110-03
作者:
易晓明1; 彭小娜2
（江西省宜春市第二人民医院内二科1，呼吸内科2，江西 宜春 336000）
Author(s):
YI Xiao-ming1; PENG Xiao-na2
(Department of Internal Medicine,Subject Two1,Department of Respiratory Medicine2,the Second People’s Hospital of Yichun City,Yichun 336000,Jiangxi,China)
关键词:
支气管哮喘; 氧气驱动雾化吸入; 肺功能; 血氧饱和度
Keywords:
Bronchial asthma; Oxygen-driven aerosol inhalation; Pulmonary function; Blood oxygen saturation
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2019.23.030
文献标志码:
A
摘要:
目的 探讨氧气驱动雾化吸入对支气管哮喘患者肺功能及血氧饱和度的影响。方法 选取2017年3月~2019年3月我院收治的86例支气管哮喘患者，按照随机数字表法分为对照组和观察组，各43例。对照组实施超声雾化吸入治疗，观察组实施氧气驱动雾化吸入治疗，比较两组肺功能指标（PA-aDO2、FEV1、PEF及RI）、血氧饱和度及不良反应发生率。结果 治疗后，观察组PA-aDO2、RI低于对照组[（2.40±0.39）kPa vs（2.97±0.42）kPa]、[（0.18±0.08）vs（0.29±0.06）]，FEV1、PEF高于对照组[（2.01±0.16）L vs（1.46±0.18）L]、[（125.29±9.68）ml/min vs（108.55±8.79）ml/min]，差异有统计学意义（P＜0.05）。观察组血氧饱和度高于对照组[（95.04±2.53）% vs（88.63±2.42）%]，差异有统计学意义（P＜0.05）。两组不良反应发生率比较（6.98% vs 11.63%），差异无统计学意义（P＞0.05）。结论 氧气驱动雾化吸入可有效增强支气管哮喘患者肺功能，提高血氧饱和度，且不增加不良反应。
Abstract:
Objective To investigate the effects of oxygen-driven aerosol inhalation on lung function and oxygen saturation in patients with bronchial asthma. Methods 86 patients with bronchial asthma admitted to our hospital from March 2017 to March 2019 were randomly divided into the control group and the observation group, 43 cases each. Ultrasonic nebulization inhalation was performed in the control group, and oxygen-driven nebulization inhalation was performed in the observation group. The lung function indexes (PA-aDO2, FEV1, PEF and RI), blood oxygen saturation and adverse reaction rate were compared between the two groups.Results After treatment, the observation group PA-aDO2, RI was lower than the control group [(2.40±0.39) kPa vs (2.97±0.42) kPa], [(0.18±0.08) vs (0.29±0.06)], FEV1, PEF was higher than the control group [(2.01±0.16) L vs (1.46±0.18) L], [(125.29±9.68) ml/min vs (108.55±8.79) ml/min], the difference was statistically significant (P<0.05). The oxygen saturation of the observation group was higher than that of the control group [(95.04±2.53)% vs (88.63±2.42)%], the difference was statistically significant (P<0.05). The incidence of adverse reactions was compared between the two groups (6.98% vs 11.63%),the difference was not statistically significant (P>0.05).Conclusion Oxygen-driven aerosol inhalation can effectively enhance lung function and improve oxygen saturation in patients with bronchial asthma without increasing adverse reactions.

参考文献/References:

[1]王磊,郝海龙.吸入性糖皮质激素对支气管哮喘的气道高反应性和炎性介质的影响[J].山西医药杂志,2017,46(24):3068-3070.[2]都瑾.布地奈德雾化吸入治疗对哮喘患者呼吸道症状及血清IL-1β、IL-12水平的影响[J].山东医药,2016,56(21):56-57.[3]张立梅,周玉琴.糖皮质激素联合白三烯受体拮抗剂治疗儿童哮喘的疗效分析[J].山西医药杂志,2016,45(2):194-196.[4]张云,张晓,黄治华.雾化吸入对小儿哮喘调节性T细胞及气道炎症的治疗效果[J].河北医药,2016,38(19):2942-2944.[5]周权,徐化强.雾化吸入高剂量糖皮质激素对成人中重度支气管哮喘急性发作的疗效[J].临床和实验医学杂志,2016,35(18):269-274.[6]陈彦飞,石茹,杨凤琴,等.不同雾化吸入方式治疗小儿哮喘伴抑郁的疗效比较[J].国际精神病学杂志,2016,43(3):477-479.[7]钟婉红,陈兰,王秀娟,等.氧气驱动与压缩空气泵雾化吸入法治疗咳嗽变异性哮喘效果比较[J].海南医学,2017,28(18):3065-3067.[8]张磊.氧气驱动雾化吸入布地奈德治疗急性喉炎的疗效研究[J].海南医学院学报,2016,22(2):206-208.

相似文献/References:

[1]焦龙龙,郭悦鹏.初诊哮喘患者的呼出气一氧化氮与大小气道功能的 相关性及临床价值分析[J].医学信息,2018,31(06):70.[doi:10.3969/j.issn.1006-1959.2018.06.022]
　JIAO Long-long,GUO Yue-peng.Correlation and Clinical Value Analysis of Exhaled Nitric Oxide and Airway Function in Patients with Newly Diagnosed Asthma[J].Medical Information,2018,31(23):70.[doi:10.3969/j.issn.1006-1959.2018.06.022]
[2]刘玉振.孟鲁司特治疗支气管哮喘的临床研究[J].医学信息,2018,31(10):140.[doi:10.3969/j.issn.1006-1959.2018.10.047]
　LIU Yu-zhen.Clinical Study of Montelukast in the Treatment of Bronchial Asthma[J].Medical Information,2018,31(23):140.[doi:10.3969/j.issn.1006-1959.2018.10.047]
[3]井庆彦.治未病三伏贴对支气管哮喘缓解期患者 冬病夏治的疗效观察[J].医学信息,2018,31(17):143.[doi:10.3969/j.issn.1006-1959.2018.17.045]
　JING Qing-yan.Therapeutic Effect of Preventive Treatment of Disease of Sanfu Paster on Summer Treatment of Winter Disease in Patients with Bronchial Asthma[J].Medical Information,2018,31(23):143.[doi:10.3969/j.issn.1006-1959.2018.17.045]
[4]赵 静,陈华琴,张 宁,等.血清骨膜蛋白和脂联素联检诊断儿童支气管哮喘价值研究[J].医学信息,2018,31(21):71.[doi:10.3969/j.issn.1006-1959.2018.21.019]
　ZHAO Jing,CHEN Hua-qin,ZHANG Ning,et al.Diagnostic Value of Serum Periosteal Protein and Adiponectin in Children with Bronchial Asthma[J].Medical Information,2018,31(23):71.[doi:10.3969/j.issn.1006-1959.2018.21.019]
[5]王晓燕,梁 萍,董艳婷.非特异性免疫疗法在支气管哮喘治疗中的应用进展[J].医学信息,2019,32(05):57.[doi:10.3969/j.issn.1006-1959.2019.05.018]
　WANG Xiao-yan,LIANG Ping,DONG Yan-ting.Progress in the Application of Non-specific Immunotherapy in the Treatment of Bronchial Asthma[J].Medical Information,2019,32(23):57.[doi:10.3969/j.issn.1006-1959.2019.05.018]
[6]孟琳非,黄伟健,酆孟洁,等.基于聚类分析对慢性肺部疾病表型的研究进展[J].医学信息,2019,32(07):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
　MENG Lin-fei,HUANG Wei-jian,FENG Meng-jie,et al.Advances in Research on Phenotypes of Chronic Lung Diseases Based on Cluster Analysis[J].Medical Information,2019,32(23):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
[7]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
　WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Medical Information,2019,32(23):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
[8]王启龙,张 蔚.支气管哮喘急性发作并肺部感染患者血清炎性因子、免疫球蛋白水平与预后的相关性分析[J].医学信息,2021,34(22):81.[doi:10.3969/j.issn.1006-1959.2021.22.024]
　WANG Qi-long,ZHANG Wei.Correlation Analysis of Serum Inflammatory Factors, Immunoglobulin Levels and Prognosis in Patients with Acute Exacerbation of Bronchial Asthma Complicated with Pulmonary Infection[J].Medical Information,2021,34(23):81.[doi:10.3969/j.issn.1006-1959.2021.22.024]
[9]丁晓燕,丁惠芳.支气管哮喘患儿缓解期呼出气一氧化氮水平与肺功能的相关性研究[J].医学信息,2021,34(24):68.[doi:10.3969/j.issn.1006-1959.2021.24.014]
　DING Xiao-yan,DING Hui-fang.Correlation Between Respiratory Nitric Oxide Level and Lung Function in Children with Bronchial Asthma During Remission Period[J].Medical Information,2021,34(23):68.[doi:10.3969/j.issn.1006-1959.2021.24.014]
[10]杨一民,黄小玲,李 溦,等.LTA4H基因多态性对汉族儿童支气管哮喘患者使用孟鲁司特钠疗效及肺功能的影响[J].医学信息,2022,35(20):49.[doi:10.3969/j.issn.1006-1959.2022.20.011]
　YANG Yi-min,HUANG Xiao-ling,LI Wei,et al.Effect of LTA4H Gene Polymorphism on the Efficacy and Lung Function of Montelukast Sodium in Chinese Han Children with Bronchial Asthma[J].Medical Information,2022,35(23):49.[doi:10.3969/j.issn.1006-1959.2022.20.011]

更新日期/Last Update: 2019-12-01